Concepedia

Sagar Shelake

SS

Statistics

Publications

5

Citations

291

H-Index

5

Active since

2014

Affiliations

Sidney Kimmel Comprehensive Cancer Center(Current)

Johns Hopkins Medicine

Johns Hopkins University

University of North Texas Health Science Center

University of North Texas

Sagar Shelake is an author at Sidney Kimmel Comprehensive Cancer Center specializing in medicine, oncology, and targeted cancer therapy.

ORCID

Publications per year

2014–2021

5

Publications

5

Peptide-based PET quantifies target engagement of PD-L1 therapeutics

Dhiraj Kumar, Ala Lisok, Elyes Dahmane et al. · Journal of Clinical Investigation · 2018 · 141 citations · Full text

, , +17

Small molecule tolfenamic acid and dietary spice curcumin treatment enhances antiproliferative effect in pancreatic cancer cells via suppressing Sp1, disrupting NF-kB translocation to nucleus and cell cycle phase distribution

Riyaz Basha, Sarah F. Connelly, Umesh T. Sankpal et al. · The Journal of Nutritional Biochemistry · 2016 · 49 citations · Full text

, , +7

Pharmacodynamic measures within tumors expose differential activity of PD(L)-1 antibody therapeutics

Dhiraj Kumar, Akhilesh Mishra, Ala Lisok et al. · Proceedings of the National Academy of Sciences · 2021 · 45 citations · Full text

, , +17

TGF-β Signaling Initiated in Dendritic Cells Instructs Suppressive Effects on Th17 Differentiation at the Site of Neuroinflammation

Suzanne Speck, James Lim, Sagar Shelake et al. · PLoS ONE · 2014 · 28 citations · Full text

, , +15

Targeting specificity protein 1 transcription factor and survivin using tolfenamic acid for inhibiting Ewing sarcoma cell growth

Sagar Shelake, Umesh T. Sankpal, W. Paul Bowman et al. · Investigational New Drugs · 2016 · 28 citations

, , +14

1–5 of 5